Loading ANVS…
Loading financial statements…
Import this data to Google Sheets with:
=jivedata("ANVS","financials")Full statements spill as a table. For one cell: =jivedata("ANVS","Revenue") or =jivedata("ANVS","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.
ANVS • CIK 0001477845
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Research and Development Expense | $38,790.603 | $19,995.447 | $25,215.607 | $43,769.832 |
| General and Administrative Expense | $6,244.408 | $6,699.481 | $4,479.651 | $5,761.187 |
| Operating Income (Loss) | $-45,035.011 | $-26,694.928 | $-29,695.258 | $-49,531.019 |
| Operating Expenses | $45,035.011 | $26,694.928 | $29,695.258 | $49,531.019 |
| Net Income (Loss) Attributable to Parent | $-56,204.313 | $-24,590.375 | $-28,854.197 | $-49,524.268 |
| Investment Income, Interest | — | $331.849 | $699.061 | $618.087 |
| Nonoperating Income (Expense) | $-11,169.302 | $2,104.553 | $841.061 | $6.751 |
| Weighted Average Number of Shares Outstanding, Basic | 9,023,138 | 12,182,475 | 20,551,997 | 34,797,166 |
| Weighted Average Number of Shares Outstanding, Diluted | 9,023,138 | 12,235,444 | 20,551,997 | 34,797,166 |
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Cash and Cash Equivalents, at Carrying Value | $5,754.72 | $10,551.916 | $19,532.338 | $18,728.945 |
| Assets | $10,208.264 | $13,925.633 | $21,081.625 | $22,037.091 |
| Liabilities | $17,959.11 | $4,617.987 | $4,230.375 | $26,291.709 |
| Accounts Payable, Current | $1,292.837 | $2,305.974 | $2,590.516 | $3,327.138 |
| Liabilities, Current | $4,279.11 | $3,880.987 | $3,635.375 | $6,358.709 |
| Common Stock, Value, Issued | $1.052 | $1.414 | $2.719 | $4.26 |
| Additional Paid in Capital | $102,507.189 | $144,155.694 | $180,552.19 | $191,871.978 |
| Retained Earnings (Accumulated Deficit) | $-110,259.087 | $-134,849.462 | $-163,703.659 | $-196,130.856 |
| Stockholders' Equity Attributable to Parent | $-7,750.846 | $9,307.646 | $16,851.25 | $-4,254.618 |
| Preferred Stock, Shares Authorized | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 |
| Preferred Stock, Shares Issued | 0 | 0 | 0 | 0 |
| Common Stock, Shares Authorized | 70,000,000 | 70,000,000 | 70,000,000 | 70,000,000 |
| Common Stock, Shares, Issued | 10,519,933 | 14,141,521 | 27,199,139 | 42,606,152 |
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | $-56,204.313 | $-24,590.375 | $-28,854.197 | $-49,524.268 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | $-22,622.973 | $4,797.196 | $8,980.422 | $1,598.659 |
| Net Cash Provided by (Used in) Operating Activities | $-39,967.304 | $-21,894.604 | $-25,619.703 | $-43,339.894 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $5,754.72 | $10,551.916 | $19,532.338 | $11,515.244 |
| Share-based Payment Arrangement, Noncash Expense | $4,628.406 | $3,836.77 | $1,797.676 | $2,592.649 |
| Fair Value Adjustment of Warrants | $11,837.2 | $-3,625.893 | $-142 | $-978 |
| Proceeds from Stock Options Exercised | $8.385 | $0 | $1.999 | $1.999 |
| Proceeds from Warrant Exercises | — | — | $8,025.003 | $8,025.003 |
| Net Cash Provided by (Used in) Financing Activities | $17,344.331 | $26,691.8 | $34,600.125 | $44,938.553 |
| Increase (Decrease) in Prepaid Expense and Other Assets | $-3,190.832 | $-1,079.827 | $-1,824.43 | $-1,016.139 |
| Increase (Decrease) in Accounts Payable | $-2,668.417 | $1,013.138 | $284.542 | $2,352.827 |
| Increase (Decrease) in Accrued Liabilities | $-751.012 | $-1,411.26 | $-530.154 | $1,200.759 |